Welcome to our dedicated page for Quantinuum news (Ticker: QNT), a resource for investors and traders seeking the latest updates and insights on Quantinuum stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Quantinuum's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Quantinuum's position in the market.
Quantinuum (Nasdaq: QNT) closed its upsized initial public offering of 28,000,000 Class A shares at $60.00 per share, raising $1.68 billion in gross proceeds before expenses.
The Class A common stock trades on the Nasdaq Global Market under ticker QNT, with a large global underwriting syndicate leading the deal.
Quantinuum (Nasdaq: QNT) priced its upsized initial public offering of 28,000,000 Class A shares at $60.00 per share. Underwriters have a 30-day option for up to 4,200,000 additional shares. Trading on the Nasdaq Global Market is expected to begin June 4, 2026, with closing on June 5, 2026.
Honeywell (NASDAQ: HON) announced that Quantinuum has filed a Form S-1 with the SEC for a proposed initial public offering of Class A common stock, planned to list on the Nasdaq Global Select Market under ticker QNT. The offering size and price range are not yet determined and remain subject to market conditions.
J.P. Morgan and Morgan Stanley are joint lead active book-running managers; Jefferies and Evercore ISI are also managers. The registration statement is filed but not yet effective.